首页> 外国专利> 4-estrene-3, 17-diol, 17-substitution products, esters thereof, and their production

4-estrene-3, 17-diol, 17-substitution products, esters thereof, and their production

机译:4-雌烯-3、17-二醇,17-取代产物,其酯及其生产

摘要

The invention comprises compounds of the general formula FORM:0776427/IV(b)/1 wherein A represents hydrogen or an aliphatic hydrocarbon radical containing less than 9 carbon atoms, and R and R1 are each hydrogen, or a benzoyl radical or an acyl radical derived from an aliphatic carboxylic acid containing 1 to 8 carbon atoms, and the preparation of the above compounds in which R represents hydrogen by the reduction of the corresponding 3-oxo substituted compounds by the Meerwein-Ponndorf-Verley reaction or by the use of an alkali metal borohydride or an alkali metal aluminium hydride, and the preparation of a 17a -alkyl-4-estrene-3, 17-diol of the above general formula, wherein said alkyl radical contains at least 2 carbon atoms, by the hydrogenation of a 17a -substituted-4-estrene-3,17-diol in which the 17a -substituent is an unsaturated aliphatic hydrocarbon radical containing 2 to 8 carbon atoms, e.g. in the presence of a noble metal catalyst such as palladium. The acyl radical may be a formyl, acetyl, propionyl, butyryl, pentanoyl, hexanoyl, cyclopentanacetyl, cyclopentanpriopionyl, or cyclohexanacetyl radical. The lower aliphatic hydrocarbon radical in the desired product may be a methyl, ethyl or a straight- or branch-chained propyl or butyl radical, an alkenyl radical such as a vinyl, allyl or butenyl radical, or an alkynyl such as an ethynyl, propynyl or butynyl radical. The 17a -substituent of the 4-estrene-3,17-diol reactant for the hydrogenation step may be of the ethylene or acetylene type such as a vinyl, propenyl, allyl, ethynyl, propynyl or butynyl radical. Useful starting compounds for the preparation of 17a -alkenyl and alkynyl derivatives of 4-estrene-3,17-diol are the 17a -substitution products of 19-nortestosterone in which the 17a -substituent is an unsaturated aliphatic hydrocarbon radical such as an ethynyl or allyl radical. The 3,17-diesters of the above general formula may be prepared by usual esterification methods. The 3-hydroxy group can be selectively esterified by using one molecular proportion of an acyl halide or anhydride. The 17-monoesters may be obtained by the reduction method referred to above using, for example, sodium borohydride as the reducing agent, esterification of the 3-hydroxy radical in the resulting compounds forms diesters which may contain different ester radicals. In the examples, 4-estrene-3,17-diol and the corresponding 3,17-diacetoxy, 3,17-dibenzoyloxy, 17-propionoxy and 17 - (b - cyclopentanpropionoxy) compounds, 17a -allyl-, 17a -vinyl-, 17a -methyl-and 17a - ethynyl - 4 - estrene - 3,17 - diol, 17a -ethyl-4-estrene-3,17-diol and the corresponding 3-propionoxy and 3-hemisuccinate compounds, and 17a -propyl-4-estrene-3a ,17 (and 3b ,17)-diol are prepared. Starting compounds. 17a -Substituted products of 19-nortestosterone, where the 17a -substituent is an unsaturated aliphatic hydrocarbon radical containing 2 to 8 carbon atoms, are prepared by a procedure involving the addition of acetylene, a homologue of acetylene, or an organo-metallic compound to a 17-keto-steroid, for example, 17a -ethynyl-19-nortestosterone can be prepared by the addition of acetylene to 3-methoxy-2,5(10)-estradiene followed by acid catalysed hydrolysis and isomerization of the resulting product, or 17a -allyl-19-nortestosterone can be prepared by the addition of allylmagnesium bromide to 3-methoxy-2,5(10)-estradien-17-one followed by acidic hydrolysis and isomerization of the product. In an example, allyl magnesium bromide is reacted with 3 - methoxy - 2,5(10) - estradien - 17 - one, the product is hydrolysed to form 17a -allyl-3-methoxy-2,5(10)-estradien-17-ol which is then heated with methanolic hydrogen chloride to form 17-allyl-19-nortestosterone. 17a -Ethyl-19-nortestosterine is prepared by treating 17a -ethynyl - 3 - methoxy - 1,3,5(10) - estratrien-17-ol with hydrogen in the presence of palladium on charcoal to form 17a -ethyl-3-methoxy-1,3,5 (10)-estratrien-17-ol, further treatment with liquid ammonia and lithium forms 17a -ethyl-3-methoxy-2,5(10)-estradien-17-ol, further treatment with acetic acid in refluxing methanol forms 17a -ethyl-3-oxo-5(10)-estren-17-ol which is then refluxed in methanolic hydrogen chloride. 17a -Propyl-19-nortestosterone is prepared by hydrogenating 17a -allyl-19-nortestosterone in the presence of palladium charcoal catalyst. 17a -ethynyl-19-nortestosterone is preparing by refluxing 3 - methoxy - 13 - methyl - 17a - ethynyl - 1,4,6,7,8,9,11,12,13,14,16,17 - dodeca - hydro - 15H-cyclopenta[a ]phenanthren-17-ol in methanolic aqueous hydrochloric acid.
机译:本发明包括通式的化合物,其中A代表氢或含少于9个碳原子的脂族烃基,且R和R 1各自为氢,或苯甲酰基或A。由含1至8个碳原子的脂族羧酸衍生的酰基,以及通过Meerwein-Ponndorf-Verley反应或通过使用将相应的3-氧代取代的化合物还原而制备其中R代表氢的上述化合物碱金属硼氢化物或碱金属铝氢化物的制备,以及通过氢化制备上述通式的17a-烷基-4-雌烯-3、17-二醇,其中所述烷基含有至少2个碳原子17a-取代的4-雌烯-3,17-二醇的衍生物,其中17a-取代基是含有2至8个碳原子的不饱和脂族烃基,例如在贵金属催化剂如钯的存在下。所述酰基可以是甲酰基,乙酰基,丙酰基,丁酰基,戊酰基,己酰基,环戊基乙酰基,环戊基戊二酰基或环己基乙酰基。所需产物中的低级脂族烃基可以是甲基,乙基或直链或支链的丙基或丁基,烯基如乙烯基,烯丙基或丁烯基,或炔基如乙炔基,丙炔基。或丁炔基。用于氢化步骤的4-雌烯-3,17-二醇反应物的17a-取代基可以是乙烯或乙炔类型的,例如乙烯基,丙烯基,烯丙基,乙炔基,丙炔基或丁炔基。制备4-estrene-3,17-二醇的17a-烯基和炔基衍生物的有用起始化合物是19-睾丸激素的17a-取代产物,其中17a-取代基是不饱和脂族烃基,例如乙炔基或乙炔基。烯丙基。上述通式的3,17-二酯可以通过常规的酯化方法制备。可以通过使用一种分子比例的酰基卤或酸酐来选择性地酯化3-羟基。 17-单酯可以通过使用例如硼氢化钠作为还原剂的上述还原方法获得,所得化合物中的3-羟基的酯化形成可以包含不同酯基的二酯。在实施例中,为4-雌烯基-3,17-二醇和相应的3,17-二乙酰氧基,3,17-二苯甲酰氧基,17-丙氧基和17-(b-环戊基丙氧基)化合物,17a-烯丙基-,17a-乙烯基- ,17a-甲基和17a-乙炔基-4-雌烯-3,17-二醇,17a-乙基-4-雌烯-3,17-二醇和相应的3-丙氧基和3-半琥珀酸酯化合物,以及17a-丙基-制备4-雌烯-3a,17(和3b,17)-二醇。起始化合物。通过涉及将乙炔,乙炔的同系物或有机金属化合物加入到其中的方法制备其中17a-取代基是含有2至8个碳原子的不饱和脂族烃基的17a-睾酮的17a-取代的产物。可以通过将乙炔加到3-甲氧基-2,5(10)-雌二醇中,然后酸催化水解和异构化所得产物来制备17-酮-类固醇,例如17a-乙炔基-19-睾丸激素,通过将烯丙基溴化镁加到3-甲氧基-2,5(10)-雌二醇-17-中,然后进行酸性水解和异构化,可以制备17a-烯丙基-19-睾丸激素或17a-烯丙基-19-睾丸激素。在一个实例中,使烯丙基溴化镁与3-甲氧基-2,5(10)-雌二醇-17-1反应,将产物水解以形成17a-烯丙基-3-甲氧基-2,5(10)-雌二醇-然后将17-ol与甲醇氯化氢一起加热以形成17-烯丙基-19-睾丸激素。通过在炭上钯存在下用氢处理17a-乙炔基-3-甲氧基-1,3,5(10)-estratrien-17-ol来制备17a-乙基-19-睾丸激素,形成17a-乙基-3-甲氧基-1,3,5(10)-雌三烯-17-ol,进一步用液氨和锂处理形成17a-乙基-3-甲氧基-2,5(10)-雌二醇-17-ol,用乙酸进一步处理酸在回流的甲醇中形成17a-乙基-3-氧代-5(10)-雌烯-17-醇,然后在甲醇氯化氢中回流。 17a-丙基-19-睾丸激素是通过在钯木炭催化剂存在下将17a-烯丙基-19-睾丸激素氢化来制备的。 17a-乙炔基-19-睾丸激素是通过回流3-甲氧基-13-甲基-17a-乙炔基-1,4,6,7,8,9,11,12,13,14,16,17-dodeca-加氢制备的-在甲醇盐酸水溶液中的15H-环戊[a]菲蒽-17-醇。

著录项

  • 公开/公告号GB776427A

    专利类型

  • 公开/公告日1957-06-05

    原文格式PDF

  • 申请/专利权人 G. D. SEARLE & CO.;

    申请/专利号GB19550029988

  • 发明设计人

    申请日1955-10-20

  • 分类号C07J1/00;C07J75/00;

  • 国家 GB

  • 入库时间 2022-08-23 22:11:07

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号